scholarly journals Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance

Oncogene ◽  
2012 ◽  
Vol 32 (25) ◽  
pp. 3059-3070 ◽  
Author(s):  
V Chell ◽  
K Balmanno ◽  
A S Little ◽  
M Wilson ◽  
S Andrews ◽  
...  
Author(s):  
Melanie B. Laederich ◽  
William A. Horton

Mutations that exaggerate signalling of the receptor tyrosine kinase fibroblast growth factor receptor 3 (FGFR3) give rise to achondroplasia, the most common form of dwarfism in humans. Here we review the clinical features, genetic aspects and molecular pathogenesis of achondroplasia and examine several therapeutic strategies designed to target the mutant receptor or its signalling pathways, including the use of kinase inhibitors, blocking antibodies, physiologic antagonists, RNAi and chaperone inhibitors. We conclude by discussing the challenges of treating growth plate disorders in children.


2011 ◽  
Vol 52 (17) ◽  
pp. 2228-2231 ◽  
Author(s):  
Anil R. Ekkati ◽  
Valsan Mandiyan ◽  
Krishna P. Ravindranathan ◽  
Jae H. Bae ◽  
Joseph Schlessinger ◽  
...  

2017 ◽  
Vol 16 (4) ◽  
pp. 614-624 ◽  
Author(s):  
Jharna Datta ◽  
Senthilkumar Damodaran ◽  
Hannah Parks ◽  
Cristina Ocrainiciuc ◽  
Jharna Miya ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document